NovaBay Pharmaceuticals, Inc. Assets Liabilities Change (Total)

Assets Liabilities Change (Total) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Assets Liabilities Change (Total) growth rates and interactive chart.


Highlights and Quick Summary

  • Assets Liabilities Change (Total) for the quarter ending June 30, 2022 was $182 Thousand (a 658.33% increase compared to previous quarter)
  • Year-over-year quarterly Assets Liabilities Change (Total) decreased by -68.67%
  • Annual Assets Liabilities Change (Total) for 2021 was $-38 Thousand (a -118.1% decrease from previous year)
  • Annual Assets Liabilities Change (Total) for 2020 was $210 Thousand (a -82.56% decrease from previous year)
  • Annual Assets Liabilities Change (Total) for 2019 was $1.2 Million (a -10.81% decrease from previous year)
  • Twelve month Assets Liabilities Change (Total) ending June 30, 2022 was $707 Thousand (a 794.94% increase compared to previous quarter)
  • Twelve month trailing Assets Liabilities Change (Total) increased by 308.67% year-over-year
Trailing Assets Liabilities Change (Total) for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$707 Thousand $79 Thousand $-38 Thousand $173 Thousand
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Assets Liabilities Change (Total) of NovaBay Pharmaceuticals, Inc.

Most recent Assets Liabilities Change (Total)of NBY including historical data for past 10 years.

Interactive Chart of Assets Liabilities Change (Total) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Assets Liabilities Change (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.18 $0.02
2021 $-0.08 $0.58 $-0.45 $-0.09 $-0.04
2020 $0.13 $-0.09 $-0.51 $0.68 $0.21
2019 $0.72 $0.26 $-0.4 $0.62 $1.2
2018 $-0.6 $-0.07 $0.35 $1.67 $1.35
2017 $-3.27 $1.49 $-0.38 $0.56 $-1.61
2016 $1.17 $-2.63 $-0.69 $-0.62 $-2.77
2015 $1.28 $0.98 $-1.01 $-0.23 $1.02
2014 $0.45 $1.07 $-0.29 $-0.69 $0.54
2013 $-0.1 $0.27 $1.39 $-0.56 $1.0
2012 $-0.72 $-0.09 $1.42 $-0.86 $-0.25
2011 $1.42 $-0.47

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology